Table 2.
Haplotypes/Genotypes | Patients* | Control* | p& | OR& | 95% CI& |
---|---|---|---|---|---|
E2 | 11 | 30 | < 0.001 | ||
4.3% | 16.7% | R | |||
E3 | 235 | 136 | < 0.001 | ||
91.8% | 75.6% | 0.212 | 0.103–0.437 | ||
E4 | 10 | 14 | 0.513 | ||
3.9% | 7.8% | 0.513 | 0.177–1.490 | ||
E2/E3 | 11 | 31 | < 0.001 | ||
8.6% | 33.3% | R | |||
E3/E3 | 108 | 46 | < 0.001 | ||
83.6% | 51.1% | 6.34 | 2.93–13.74 | ||
E3/E4 | 10 | 14 | 0.072 | ||
7.8% | 15.6% | 1.94 | 0.67–5.66 |
P < 0.05 values were accepted as statistically significant
*% frequency
&Logistic regression analysis